Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700019O17Rik Activators

1700019O17Rik activators encompass a diverse set of chemical compounds that enhance the functional activity of the protein through various cellular signaling pathways. For instance, Forskolin and Dibutyryl-cAMP (db-cAMP) both raise intracellular cAMP levels, leading to activation of PKA. This kinase is then able to phosphorylate specific substrates that could include 1700019O17Rik itself or proteins within its signaling pathway, therefore enhancing 1700019O17Rik's activity. Likewise, calcium ionophores like Ionomycin and A-23187 elevate intracellular calcium, which may activate calcium-dependent proteins and signaling pathways that involve 1700019O17Rik, leading to its activation. Phorbol 12-myristate 13-acetate (PMA) specifically activates PKC, which could result in the phosphorylation of 1700019O17Rik or proteins in associated pathways, whereas Sphingosine-1-phosphate engages G-protein-coupled receptors to initiate signaling cascades that could ultimately enhance 1700019O17Rik function.

The molecular landscape of 1700019O17Rik activation is further influenced by compounds that modulate various kinase activities. Epigallocatechin gallate (EGCG), a known kinase inhibitor, may selectively inhibit kinases that negatively regulate 1700019O17Rik, thereby promoting its activity. Similarly, the broad-spectrum kinase inhibitor Staurosporine may inadvertently enhance 1700019O17Rik signaling by inhibiting kinases that suppress its pathway. The PI3K inhibitor LY294002 potentially redirects signaling pathways to favor those involving 1700019O17Rik, leading to its enhanced activity. Retinoic acid, through its action on gene expression, might indirectly increase the functional activity of pathways in which 1700019O17Rik participates. In the MAPK/ERK pathway, U0126 serves as an MEK inhibitor, which could also result in the indirect activation of 1700019O17Rik by altering the pathway's dynamics. Lastly, Rapamycin, by inhibiting mTOR, could activate compensatory pathways that serve to enhance 1700019O17Rik's function, illustrating the intricate web of cellular signaling that converges on the activation of this protein.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, which can modify the activity of calcium-dependent proteins, possibly including 1700019O17Rik.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC), which may lead to phosphorylation of 1700019O17Rik or associated proteins, thereby enhancing 1700019O17Rik function.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate interacts with its receptors to initiate signaling cascades that could culminate in the activation of 1700019O17Rik through downstream effectors.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A-23187 acts as a calcium ionophore, promoting calcium influx that could activate calcium-dependent signaling pathways involving 1700019O17Rik.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid modulates gene expression through its receptors, which might enhance the activity of proteins involved in the same pathways as 1700019O17Rik.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a kinase inhibitor that might preferentially inhibit kinases that negatively regulate 1700019O17Rik, thereby enhancing the protein's activity.

Adenosine 3′,5′-cyclic monophosphate

60-92-4sc-217584
sc-217584A
sc-217584B
sc-217584C
sc-217584D
sc-217584E
100 mg
250 mg
5 g
10 g
25 g
50 g
$116.00
$179.00
$265.00
$369.00
$629.00
$1150.00
(1)

db-cAMP is a cAMP analog that activates PKA, potentially leading to the phosphorylation and activation of 1700019O17Rik or proteins within its pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that could shift signaling pathways to favor those involving 1700019O17Rik, leading to its enhanced activity.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum kinase inhibitor that might preferentially inhibit kinases in competing pathways, indirectly enhancing the pathway of 1700019O17Rik.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which could lead to the activation of alternative pathways that enhance the function of 1700019O17Rik.